Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Saved in:
Bibliographic Details
Title: Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.
Authors: Traphagen NA, Wheeler E, Li R, Lu F, Ahmed B, Tewari AK, Balk SP, Nelson PS, Corey E, Long H, D'Andrea AD, Qiu X, Brown M
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Jun 03. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2025.06.02.657429